Why medical support for safe abortion is growing in a post-Roe world
While the right to safe abortion has been restricted in the United States, elsewhere, governments are liberalising abortion laws.
Healthcare asian news
Malaysians fear 2-tier hospitals as government pushes paid-for services: ‘change is coming’
A government proposal to expand full-paying services at Malaysia’s public hospitals has raised concerns about diverting resources from an already struggling service and the potential entrenchment of a two-tier healthcare system.
Malaysia’s vape sector pleads for ‘opportunity to breathe’ as strict smoking laws loom
The health ministry will bring into force the Control of Smoking Products for Public Health Act on October 1, which will ban the sale, purchase and services related to all forms of tobacco products and tobacco substitutes – including vapes – to anyone below the age of 18.
European markets fall as investors weigh UK inflation data, look to Fed rate decision
LONDON — European markets fell on Wednesday as investors considered key data from the region and looked to the U.S. Federal Reserve interest rate decision.
Canada and New Zealand are among the 10 best countries for a comfortable retirement—the U.S. didn't make the list
A recent U.S. News and World Report ranked the best countries for a comfortable retirement based on an international survey of nearly 17,000 people and a subset of 5,900 respondents in their mid-40s and older.
Microsoft to cut 650 jobs at its Xbox gaming unit — read the full memo from top exec Phil Spencer
Microsoft on Thursday said it is cutting 650 roles at its Xbox gaming division, in the latest major round of layoffs to hit the video game industry.
Singapore’s record setting US$24 million office sale on Orchard Road signals investor interest
An office floor in a building on Singapore’s Orchard Road is being sold for a record rate, in a sign of continued investor interest in the city state’s prime market.
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.